Our intrepid West Coast reporter has pointed out a new clinical trial is recruiting WMers in Canada! Although to take advantage of it, you have to be near, or be able to travel to, Vancouver.
This trial, NCT05952037 (https://clinicaltrials.gov/study/NCT05952037), is using a new BCL-2 inhibitor, Sonrotoclax, and it is strictly for WM patients. The trial is world-wide, but is recruiting in just the one location in Canada. According to the clinicaltrials.gov website, that Canadian location is in North Vancouver, at the Lions Gate Hospital Chemotherapy Clinic.
Interestingly, the trial has several “arms” running in parallel. One of those arms is for treatment-naive patients; the other three are for Relapsed/Refractory patients with various treatment histories.
If this is the time to discuss your first, or next, treatment, you might consider asking both yourself and your hematologist, “is this trial right for me?”. Travel may, of course, be a major consideration.